COLUMN GROUP II, LP
The estimated Net Worth of COLUMN GROUP II, LP is at least $125 Million dollars dollars as of 09/17/2021. COLUMN GROUP II, LP is the 10% Owner of RAPT Therapeutics Inc. COLUMN GROUP II, LP owns over 3,146,989 shares of RAPT Therapeutics Inc stock worth over $125 Million dollars .
|RAPT Therapeutics Inc||2020-09-22||10 percent owner|
|NGM Biopharmaceuticals Inc||2020-09-01||10 percent owner|
|Nurix Therapeutics Inc||2020-07-28||10 percent owner|
|ORIC Pharmaceuticals Inc||2020-04-28||10 percent owner|
|Immune Design Corp||2019-04-02||10 percent owner|
|Gritstone Bio Inc||2018-10-02||10 percent owner|
|Arcus Biosciences Inc||2018-03-19||10 percent owner|
COLUMN GROUP II, LP trading performance
COLUMN GROUP II, LP trading performance analysis
|1 Month||3 Months||6 Months||1 Year||2 Years||3 Years|
|Relative Return to S&P 500(%)||122.49||237.33||27.66|
Column Group Ii, Lp trading transactions
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.
COLUMN GROUP II, LP personal network